Vivimed Labs’ 50:50 Joint Venture (JV) strides vivimed Pte, Singapore has received approval for Albendazole Tablets USP 200mg from the United States Food & Drug Administration (USFDA). This is the second generic approval by USFDA for Albendazole Tablets.
Albendazole Tablets is a generic version of Albenza Tablets of Amneal pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately $100 million.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
